Neuralink says it has successfully implanted another brain chip in a human patient. According to a study update shared by the company, the patient, identified by his first name, Alex, has been ...

Neuralink can now study its brain implant in humans after securing a go-ahead from the Food and Drug Administration. It’s a critical turning point for the Elon Musk-led company — but the ...

During Neuralink’s summer update on the trial, they showed the moment one participant was able to move a cursor with his ...

Neuralink’s study is estimated to have a primary completion date of 2026, with the full study expected to be complete in 2031. The study will enroll patients between the ages of 22 and 75 years ...

Neuralink is building a brain implant called the Link, which aims to help patients with severe paralysis control external technologies using only neural signals. IE 11 is not supported.

Elon Musk's Neuralink has registered a study for its brain implant with the U.S. government. The company is looking to enroll three patients for the trial, which is expected to span several years.

Neuralink announced it is recruiting for human clinical trials to test and assess the safety of its brain chip implants in a news release on Tuesday. The neural interface technology company, owned ...

Elon Musk’s Neuralink brain-computer interface company is now recruiting participants for its “first-in-human clinical trial.” The medical technology operation’s PRIME study plans to allow ...

After receiving approval from an independent review board, Neuralink is set to begin offering brain implants to paralysis patients as part of the PRIME Study, the company said.

Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study. Neuralink ...